New Guidelines for Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer!

May 12, 2017
by Stephanie Chisolm

For the first time for any type of malignancy, the American Urological Association (AUA), the American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO), and the Society of Urologic Oncology (SUO) have formulated an evidence-based guideline for the treatment of non-metastatic muscle-invasive bladder cancer. BCAN Co-Founder, Diane Z. Quale represented patients on the panel of experts that recognized the importance of multidisciplinary collaborative efforts that take into account survival and quality-of-life (QOL) concerns, as they developed the guidelines.

Read the new guidelines below:


Share this page:Share on FacebookTweet about this on TwitterShare on Google+Share on TumblrShare on LinkedInEmail this to someone